All Updates

All Updates

icon
Filter
Funding
Radar Therapeutics raises USD 13.4 million in seed funding to advance ongoing programs
Precision Medicine
May 23, 2024
Last week:
Partnerships
Geographic expansion
Lemonade partners with Homesite to expand home insurance services
InsurTech: Personal Lines
Jun 14, 2024
Funding
BayaniPay raises USD 3 million in seed funding to expand payment solutions
Neobanks
Jun 14, 2024
Partnerships
Carbonfuture and Swiss Re partner for long-term carbon removal through biochar
Carbon Management Software
Jun 13, 2024
Funding
Sidekick raises GBP 8.5 million in seed and debt funding to support expansion
Retail Trading Infrastructure
Jun 13, 2024
Partnerships
Climatiq and Epicor partner to reduce CO2 emissions in supply chains
Carbon Management Software
Jun 13, 2024
Product updates
EHang's pilotless eVTOL aircraft concludes first flight launch in Saudi Arabia
Passenger eVTOL Aircraft
Jun 13, 2024
Partnerships
Skyports partners with Unified Aviation to accelerate global network release
Passenger eVTOL Aircraft
Jun 13, 2024
Partnerships
Industry news
USSF chooses Blue Origin, SpaceX, and ULA for ~USD 5.6 billion Pentagon launch contracts
Space Travel and Exploration Tech
Jun 13, 2024
Funding
AnyCreek raises USD 1.8 million in seed funding to enhance platform and expand into new markets
Travel Tech
Jun 13, 2024
Funding
Zeta Labs raises USD 2.9 million in pre-seed funding to develop autonomous AI agent
Generative AI Applications
Jun 13, 2024
Precision Medicine

Precision Medicine

May 23, 2024

Radar Therapeutics raises USD 13.4 million in seed funding to advance ongoing programs

Funding

  • Radar Therapeutics has raised USD 13.4 million in an oversubscribed seed funding round led by NfX Bio, with participation from Eli Lilly and Company, Biovision Ventures, and KdT Ventures, among others.

  • The raised funds are expected to be channeled toward advancing Radar’s internal programs, including its programmable mRNA-based therapeutics, team expansion, and strategic partnering initiatives. 

  • Radar Therapeutics is a biotechnology company specializing in developing advanced programmable genetic and mRNA-based therapeutics that use RNA sensors. Its RADAR platform enables precision therapeutics through controlled reading of the mRNA in targeted cells, protecting non-target cells from toxic side effects.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.